Increased Serum Anti-Carbonic Anhydrase II Antibodies in Patients with Graves' Disease

Abstract

Carbonic anhydrase II (CA II) has an important role in thyroid hormone synthesis via regulating iodide (I^-) transport across thyroidal cell membranes and the existence of autoantibodies against CA I and/or CA II have been shown in sera from patient with various autoimmune diseases such as Sjögren's Syndrome, Systemic Lupus Erythmatosus, type 1 diabetes, primary biliary cirrhosis and ulcerative colitis. The aim of this study was to investigate the presence of anti-CA I and CA II antibodies in autoimmune thyroid disease and the relationships between the autoantibodies and other clinical parameters. We studied 40 autoimmune thyroid patients (20 Hashimoto's thyroiditis, HT and 20 Graves' disease, GD ) and 21 healthy control subjects. Serum anti-CA I and CA II antibodies were screened by ELISA. Positive rate of anti-CA II (25%) antibody was significantly higher in GD patients as compared to HT patients and control subjects (p<0.05). There were no significant changes in positive rate of anti-CA I antibody. In addition, a significant correlation between serum anti-CA antibodies titers and other studied clinical parameters was not found. The results suggest that anti-CA II antibodies may be involved in the pathogenesis of GD.

Hashimoto's thyroiditis - Graves' disease - anti-CA II antibody - anti-CA I antibody

References

• 1 Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies.  Annual Review Biochemistry. 1995;  64 375-401
• 2 Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A. Carbonic anhydrase inhibitors: sulfonamides as tumor agent?.  Bioorganic & Medicinal Chemistry. 2001;  9 703-714
• 3 Chow SY, Kemp JW, Woodbury DM. Role of carbonic anhydrase in Thyroidal iodide transport.  Annals New York Academy of Science. 1984;  429 604-606
• 4 Inagaki Y, Jinno-Yoshida Y, Hamasaki Y, Ueki H. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome.  Journal of Dermatological Science. 1991;  2 147-154
• 5 Nishimori I, Bratonova T, Toshkov I, Caffrey T, Mogaki M, Shibata Y, Hollingsworth MA. Induction of Experimental autoimmune sialodenitis by immunization of PL/J mice with carbonic anhydrase II.  The journal of immulogy. 1995;  154 4865-4873
• 6 Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, Ohana M, Matsushima Y, Omori K, Chiba T. Experimental immune-mediated pancreatitis in neonatally Thymectomized mice immunized with carbonic anhydrase II and lactoferrin.  Laboratory Investigation. 2002;  82 411-424
• 7 Itoh Y, Reichlin M. Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic disease.  Arthritis Rheumatism. 1992;  35 73-82
• 8 Kiechle FL, Quattrocıocchı-Longe TM, Brinton DA. Carbonic anhydrase antibody in sera from patients with endometriosis.  American Journal of Clinical Pathology. 1994;  101 611-615
• 9 Reimand K, Talja I, Metsküla K, Kadastik Ü, Matt K, Uibo R. Autoantibody studies of female patients with reproductive failure.  Journal of Reproductive Immunology. 2001;  51 167-176
• 10 Taniguchi T, Okazaki K, Okamoto M, Seko S, Tanaka J, UchidaK, Nagashima K, Kurose T, Yamada Y, Chiba T, Seino Y. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of pancreas.  Pancreas. 2003;  27 26-30
• 11 Invernizzi P, Battezzati PM, Crosignani A, Zermiani P, Bignotto M, Del Papa N, Zuin M, Podda M. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis irrespective of antimitochondrial antibody status.  Clinical and Experimental Immunology. 1998;  144 448-454
• 12 Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onish S, Holigsworth MA. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome.  Gastroenterology. 1996;  110 1579-1586
• 13 Andoh A, Fujiyama Y, Yoshioka U, Sasaki M, Araki Y, Tsujikawa T, Bamba T. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.  International Journal of Molecular Medicine. 2002;  9 499-502
• 14 Marazuela M. Lymphocyte traffic and homing in autoimmune thyroid disorders.  European Journal of Endocrinology. 1999;  14 287-290
• 15 Collins J, Gough S. Autoimmunity in thyroid disease.  European Journal of Nuclear Medicine. 2002;  29 ((Suppl 2)) 417-424
• 16 Weetman AP. Non-thyroid autoantibodies in thyroid disease.  Best Practice & Research Clinical Endocrinology & Metabolism. 2004;  19 ((1)) 17-32
• 17 Nishimori I, Okazaki K, Yamamoto Y, Morita M, Tamura S, Yamamoto Y. Specific cellular immune response to pancreatic antigen in chronic pancreatitis and Sjögren's syndrome.  Journal of Clinical Immunology. 1993;  13 265
• 18 Parkkila S, Parkkila A. Carbonic anhydrase in alimentary tract. Roles of the different isoenzymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal.  Scandinavian Journal of Gastroenterology. 1996;  31 305-317
• 19 Kumpulainen T. Immunohistochemical localization of human carbonic anhydrase isoenzymes.  Annals New York Academy of Science. 1984;  429 359-368
• 20 Scofield RH. Autoantibodies as predictors of disease.  Lancet. 2004;  363 1544-1546
• 21 Punzi P, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations.  Joint Bone Spine. 2004;  71 275-283
• 22 Botré F, Botré C, Podesta E, Podda M, Invernizzi P. Effect of anti-carbonic anhydrase antibodies on carbonic anhydrase I and II.  Clinical Chemistry. 2003;  49 ((7)) 1221-1223
• 23 Rojas R, Apodaca G. Immunoglobulin transport across polarized epithelial cells.  Nature Reviews, Molecular Cell Biology. 2002;  3 ((12)) 944-955

Correspondence